Key Takeaways

  • The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum global standards for IP protection among World Trade Organization (WTO) members.
  • TRIPS covers copyrights, patents, trademarks, industrial designs, trade secrets, and geographical indications.
  • The TRIPS Council monitors compliance, fosters dialogue, and reviews IP developments across member states.
  • Developing nations face challenges in balancing IP protection with access to medicine, technology, and innovation.
  • Amendments like the Doha Declaration and subsequent waivers have clarified how TRIPS interacts with public health and development priorities.
  • Ongoing debates focus on how TRIPS affects digital trade, biotechnology, and equitable access to innovation.

Trade-related aspects of intellectual property rights, also referred to as TRIPS, is an agreement that ties trade and intellectual property together. Generally, developing countries have opposed non-tariff barriers, such as the protection of inventions, since they believe that it prevents them from trading competitively worldwide.

TRIPS Agreement Controversy

Therefore, there has been controversy between the TRIPS Agreement and other international agreements, including the Convention on Biological Diversity. The controversy involves the following issues:

  1. Access to creating similar chemicals, fertilizers, and drugs
  2. Access to using and growing patent-protected plant species, particularly if the patent holder is a large corporation that doesn’t actually do business in the farming industry
  3. Access to importing pharmaceuticals to under-developed countries that wouldn’t otherwise be able to produce such drugs

For these reasons, the TRIPS Agreement is consistently changing and evolving as these controversies and debates continue. But the TRIPS Agreement aims to balance its long-term goal of fostering research and development on new products with its short-term goal of ensuring that those businesses with products that can be easily copied or re-created can obtain patent protection to prevent other businesses from utilizing the invention.

Some developing countries believe that patents and other IP rights fail to contribute to the development or poverty reduction worldwide. They believe that their rights are being distorted in favor of larger, more established companies, which limits their opportunities. In turn, the poor nations become poorer and the wealthy nations become wealthier.

However, a counter-argument to this is that businesses are hesitant to invest in poorer countries since such countries don’t allow protection of their inventions. Therefore, anyone in that country can in fact steal the invention or product and create an imitation of it, thereafter selling it as his or her own. The counter-argument also states that protecting such IP rights further promotes research and development, as businesses would be highly reluctant to spend significant time and resources on new inventions if they know that their hard work and time spent on it isn’t protected from infringement.

Objectives and Scope of the TRIPS Agreement

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is one of the most comprehensive international agreements on intellectual property. It was adopted in 1994 as part of the World Trade Organization (WTO) framework and aims to harmonize IP protection standards across member nations. TRIPS ensures that intellectual property rights (IPRs) are not isolated from trade policies, making them enforceable through WTO mechanisms.

The agreement covers key IP categories, including:

  • Copyright and related rights: Protects literary, artistic, and scientific works.
  • Trademarks: Safeguards distinctive signs identifying goods or services.
  • Geographical indications: Protects product names tied to regional origin (e.g., Champagne).
  • Patents: Provides exclusive rights for inventions for a minimum of 20 years.
  • Industrial designs and trade secrets: Ensures fair competition and innovation incentives.

TRIPS also establishes minimum enforcement standards, requiring WTO members to provide legal remedies for infringement and to maintain transparent and predictable IP systems.

WTO and the TRIPS Agreement

The WTO, or World Trade Organization, is an international organization that creates rules of trade between nations. As of February 2005, there were 148 member countries of the WTO. All member countries must adhere to 18 agreements that are annexed to the Agreement; the countries cannot choose to be a party to some but not others. The TRIPS Agreement is one of these 18 agreements, which has the greatest impact on the pharmaceutical industry to address drug-making processes and inventions.

Functions of the TRIPS Council

The Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS Council) oversees the implementation and enforcement of the agreement. It serves as a forum for member states to discuss IP-related trade issues, review national laws, and address emerging challenges such as digital piracy, biotechnology, and genetic resource protection.

The Council also:

  • Monitors compliance with TRIPS provisions and reviews national IP policies.
  • Facilitates technical cooperation to help developing countries align their legal systems with TRIPS standards.
  • Collaborates with organizations such as the World Intellectual Property Organization (WIPO) to promote coherent global IP frameworks.

Regular meetings of the TRIPS Council enable ongoing adaptation to new technologies and trade developments, ensuring the agreement remains relevant to both developed and developing economies.

TRIPS and Public Health

Over the years, there has been great attention on public health in developing countries, including HIV/AIDS. The TRIPS Agreement provides that under certain circumstances, anyone can manufacture or import patent products without the holder’s consent. This is known as compulsory licensing. In this type of licensing, the patent holder isn’t willing to sell or voluntarily enter into a license agreement on any reasonable terms. However, such compulsory license is limited to certain products under the TRIPS Agreement, which hinders developing countries to manufacturing or selling the patent holder’s drug that isn’t sold in that country. Therefore, those living in under-developed countries don’t have access to the types of pharmaceuticals that are available in the United States.

This public health problem was discussed in a Ministerial Declaration that was adopted at the Doha Ministerial Conference in 2001. The Declaration emphasized that TRIPS shouldn’t prevent any WTO members from protecting public health, even if that meant allowing compulsory licenses. Even if this does occur, however, under-developed countries might not have the ability to import compulsory-licensed pharmaceuticals. Specifically, Norway has been a big advocate on public health issues, and believes that compulsory licensing should be allowed in its country. An agreement was finally signed in 2003, which provides a waiver in relation to the TRIPS Agreement. It specifically allows pharmaceuticals that are manufactured under a compulsory license to be imported into poor countries that lack production capability. This waiver then became permanent language in the TRIPS Agreement, meaning that Agreement was fully amended to allow the exportation of such drugs.

TRIPS Flexibilities and the Doha Declaration

One of the most important milestones in TRIPS history was the 2001 Doha Declaration on the TRIPS Agreement and Public Health. It reaffirmed that TRIPS should not prevent member countries from protecting public health and promoting access to essential medicines. The declaration clarified that countries may use compulsory licensing and parallel importing to address public health crises like HIV/AIDS, malaria, and tuberculosis.

In 2003, the WTO General Council adopted a decision allowing the export of medicines produced under compulsory licenses to countries lacking manufacturing capacity. This measure later became a permanent amendment to TRIPS in 2005, illustrating the agreement’s adaptability to global health challenges.

Developing nations continue to advocate for greater flexibility in IP enforcement to ensure affordable access to medicines while maintaining incentives for pharmaceutical innovation.

Emerging Issues and Future Directions

The TRIPS Agreement continues to evolve as new forms of innovation emerge. Ongoing discussions within the WTO focus on:

  • Digital and internet-based innovations: Addressing IP protection for digital goods, software, and online content.
  • Traditional knowledge and genetic resources: Ensuring that indigenous communities benefit from the use of their cultural or biological assets.
  • Sustainability and green technologies: Facilitating technology transfer for environmental innovations.

Future reforms may also explore how TRIPS can better balance public interest, innovation incentives, and equitable global trade. Many developing countries seek technical assistance and capacity-building to help them implement IP protection systems that foster innovation without hindering access to essential technologies.

Frequently Asked Questions

1. What does TRIPS stand for?

TRIPS stands for the Agreement on Trade-Related Aspects of Intellectual Property Rights, a WTO treaty that sets global minimum standards for IP protection.

2. Why is TRIPS important for developing countries?

TRIPS provides access to international trade benefits but also creates challenges, as strict IP protections can impact access to affordable medicines and technologies.

3. How does TRIPS relate to public health?

The Doha Declaration clarified that TRIPS should not restrict governments from ensuring access to life-saving medicines through measures like compulsory licensing.

4. What is the role of the TRIPS Council?

The TRIPS Council monitors the agreement’s implementation, promotes cooperation, and provides a platform for discussing IP-related trade concerns.

5. How is TRIPS adapting to digital innovation?

TRIPS discussions now include digital IP issues, such as online piracy, data protection, and the fair use of AI-generated content, ensuring the agreement remains relevant in the digital economy.

If you need help learning more about trade-related aspects of intellectual property rights, you can post your legal need on UpCounsel’s marketplace. UpCounsel accepts only the top 5-percent of lawyers to its site. Lawyers on UpCounsel come from law schools such as Harvard Law and Yale Law, and average 14 years of legal experience, including work with or on behalf of companies like Google, Menlo Ventures, and Airbnb.